R&D tax credits were implemented in 1981 to reverse a dramatic decline in R&D and boost the economy. They don't work. It's time to end them. » Read More
Investors seeking steady gains on innovation should look past tech buzz. When R&D productivity is measured, 'boring' stocks often lead.
The CNBC RQ 50 identifies companies that don't just spend big on R&D, but spend right, creating return on innovation for shareholders.
Using the CNBC RQ 50 measure for R&D productivity, we've identified an elite group of companies that merit election to an R&D hall of fame.
CNBC launches its first RQ 50 list, a predictive tool to find stocks with a highly competitive R&D growth and innovation strategy.
CNBC's Dominic Chu breaks down AMD and Intel to see which chip company is the most efficient allocator of research and developmental capital.
CNBC's Dominic Chu looks at how well Salix Pharmaceuticals and Vertex allocate spending on research and developmental capital.
CNBC's Dominic Chu looks at how well Lockheed Martin and Northrop Grumman allocate spending on research and developmental capital.
CNBC's Dominic Chu, breaks down Apple and Hewlett-Packard to see which company best optimizes R&D spending and creates the greatest shareholder value.
CNBC's Dominic Chu breaks down Mattel and Hasbro to see which company is the most efficient allocator of research and developmental capital.
CNBC's Dominic Chu, crunches the numbers to find out which company offers shareholders the greatest value.
This special report focuses on how individual investors strategically juggle their many savings goals and objectives.
A look at 50 private companies set to reshape the business landscape.
Business icons and provocateurs share their innovative models. Learn how to upend old industries and start new ones that move markets.